State IL
Clinical Trials in Illinois
Recruiting clinical trials with at least one study location in Illinois. Data updated daily from ClinicalTrials.gov.
Top Conditions in Illinois
NCT06545331 Phase 1
Recruiting
Study of XB010 in Subjects With Solid Tumors
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
396 pts
Location
United States, United Kingdom
Sponsor
Exelixis
NCT05599750 N/A
Recruiting
Suture Repair vs Mesh Repair for Incisional Hernia
Condition
Incisional Hernia
Enrollment
154 pts
Location
United States
Sponsor
Clayton Petro
NCT05336890 N/A
Recruiting
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Ne...
Condition
Premature Birth
Enrollment
500 pts
Location
United States
Sponsor
Ann & Robert H Lurie Children'
NCT07043400 Phase 3
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versu...
Condition
Metastatic Gastric Adenocarcinoma
Enrollment
351 pts
Location
United States, Austria, Brazil
Sponsor
BeOne Medicines
NCT06022822 Phase 2
Recruiting
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Can...
Condition
Prostate Adenocarcinoma
Enrollment
90 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06439277 Phase 3
Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidit...
Condition
Obesity
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT04107077 Phase 2
Recruiting
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemo...
Condition
Gastric Cancer
Enrollment
21 pts
Location
United States
Sponsor
University of Chicago
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastati...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05408845 Phase 2
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Ch...
Condition
Metastatic Salivary Gland Carcinoma
Enrollment
146 pts
Location
United States
Sponsor
NRG Oncology
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
NCT07418112 Phase 4
Recruiting
Comparing the Efficacy and Safety of Holmium Laser Lithotripsy Versus Electrohyd...
Condition
Choledocholithiasis
Enrollment
40 pts
Location
United States
Sponsor
Rush University Medical Center
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
NCT06676956 N/A
Recruiting
The SEQUENCE Trial: Evaluating Diagnostic Yield of Robotic-assisted Bronchoscopy...
Condition
Pulmonary Nodules
Enrollment
320 pts
Location
United States
Sponsor
Northwestern University
NCT06232512 N/A
Recruiting
Multimodal Haptic Feedback for Plantar Sensory Substitution
Condition
Hypoesthesia
Enrollment
100 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT06879912 N/A
Recruiting
A Study to Understand the Utility of the Force Feedback Instruments in Robotic P...
Condition
Hernia, Inguinal
Enrollment
200 pts
Location
United States
Sponsor
Intuitive Surgical
NCT02074839 Phase 1
Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malign...
Condition
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
291 pts
Location
United States, France
Sponsor
Institut de Recherches Interna
NCT05557279 Phase 4
Recruiting
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Wome...
Condition
Overactive Bladder
Enrollment
40 pts
Location
United States
Sponsor
Loyola University
NCT06343402 Phase 1
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung...
Condition
Non-small Cell Lung Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
TheRas, Inc., d/b/a BBOT (Brid
NCT05555095 N/A
Recruiting
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
Condition
Hypertension
Enrollment
19,331 pts
Location
United States
Sponsor
OSF Healthcare System
NCT06769464 N/A
Recruiting
Electrophysiological Representations of Odor in the Human Brain Study 1
Condition
Odor Intensity Ratings
Enrollment
28 pts
Location
United States
Sponsor
Northwestern University
NCT05605899 Phase 3
Recruiting
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-...
Condition
High-risk Large B-cell Lymphoma (LBCL)
Enrollment
300 pts
Location
United States, Australia, Austria
Sponsor
Kite, A Gilead Company
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca